MEDIASSIST Q2 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹233 Cr
verified against source
Revenue YoY
28.6%
reported change
EBITDA
₹39.7 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Medi Assist reported Q2 FY26 revenue from operations of ₹233.5 crore (+28.6% YoY), driven by robust growth in group premium administered (₹11,447 crore, +22.5% YoY) and strong performance with private insurers (+28.3% YoY vs industry 7.8%). However, EBITDA margin compressed sharply to 17.1% (down ~500bps sequentially) due to Paramount integration costs (~150bps impact) and incremental technology investments (~100bps impact), resulting in PAT of just ₹8.1 crore (-61.5% YoY). H1 EBITDA margin of 19.3% reflects similar pressures. Management expects Paramount integration to normalize margins to 22-23% within 4-5 quarters as annual policy renewals complete. The company maintains strong market position at 21.2% health insurance market share (up from 19.2%) and tech-driven savings of ₹230 crore (+50% YoY). Key risks include prolonged margin compression from acquisition integration, elevated depreciation from acquired intangibles (~₹3.5 crore/quarter), and relatively low retail market share (5.3%) despite GST tailwinds.
Colored figures show movement against the previous available record.
Guidance to track
- Management expects to return to 22-23% EBITDA margin profile within 4-5 quarters as Paramount integration completes and annual policy renewals normalize.
- Company targets becoming debt-free by March-April 2026, with ~₹150 crore of the current ₹242 crore debt to be cleared in the next 1-2 months.
- Full scale deployment of Matrix platform for STAR Health achieved in under 6 months; volume migration expected over 2-3 quarters with revenue recognition as migration completes.
- Due to ~₹3.5 crore/quarter incremental D&A from Paramount intangibles, reported PAT will remain below normalized levels even as cash profits recover.
Risks flagged
- Paramount integration causing ~150bps EBITDA margin impact in Q2; combined with 100bps tech investments, total margin drag is ~250bps. Analyst questioned whether the 4-5 quarter guidance is achievable given sequential 500bps margin decline.
- PAT declined 61.5% YoY to ₹8.1 crore in Q2, driven by lower EBITDA margins and higher D&A from Paramount acquisition. Analyst raised concern about normalized profitability trajectory.
- Trade receivables increased sharply due to timing issues with September-October collections from large projects. Management attributed this to seasonality but acknowledged DSO impact.
- Retail segment market share declined to 5.3% from 5.6% YoY despite GST tailwinds expected to benefit retail health insurance. Company attributed this to discretionary retail business mix.
Key quotes
- We are among the most stable management in the organization that has worked through the years and through the investing and posting. So first there is really no connection between holding and the management.
- In general in four to five quarters you should see the combined business getting back closer to the original margin profile that is prior to the acquisition.
- This is likely to be the runway for few more years till the time this entire customer retention relationship amount gets normalized.
Research modules